The development of hyperpolarizing inhibition is an important step in the maturation of neuronal networks. Hyperpolarizing inhibition requires Cl Ϫ outward transport that is accomplished by KCC2, a K ϩ /Cl Ϫ cotransporter. We show that cultured hippocampal neurons initially contain an inactive form of the KCC2 protein, which becomes activated during subsequent maturation of the neurons. We also show that this process is accelerated by transient stimulation of IGF-1 receptors. Because the transporter can be rapidly activated by coapplication of IGF-1 and an Src kinase and can be deactivated by membrane-permeable protein tyrosine kinase inhibitors, we suggest that activation of K ϩ /Cl Ϫ cotransporter function by endogenous protein tyrosine kinases mediates the developmental switch of GABAergic responses to hyperpolarizing inhibition.
In the developing rat hippocampus, fast GABAergic transmission is depolarizing early in development and becomes hyperpolarizing and strictly inhibitory only by the end of the first postnatal week (Cherubini et al., 1991) . The direction of Cl Ϫ currents flowing through GABA A receptors depends on the transmembranal gradient for Cl Ϫ currents. Cl Ϫ influx requires low levels of intracellular [Cl Ϫ ], which is achieved by extrusion of Cl Ϫ by a furosemide-sensitive transporter (Misgeld et al., 1986; Thompson et al., 1988; Jarolimek et al., 1999; Kakazu et al., 1999 ) whose driving force is determined by extracellular [K ϩ ] (Payne, 1997; Jarolimek et al., 1999) . There is considerable evidence suggesting that the recently cloned neuronal K ϩ /Cl Ϫ cotransporter, KCC2, accomplishes this transport (Payne et al., 1996) . A reduction in the expression of KCC2 by antisense nucleotides was shown to decrease the driving force for hyperpolarizing GABA currents in hippocampal CA1 neurons (Rivera et al., 1999) . KCC2 expression increases in forebrain regions during the first postnatal weeks (Clayton et al., 1998; Lu et al., 1999; Rivera et al., 1999) . At approximately this time, GABA A and glycine receptor responses become hyperpolarizing (Ehrlich et al., 1999; Kakazu et al., 1999; Rivera et al., 1999; DeFazio et al., 2000) , and giant depolarizing potentials that are blocked by GABA A receptor antagonists disappear in the hippocampus (Ben-Ari et al., 1989) . That KCC2 is the dominant neuronal Cl Ϫ extruding molecule, is important for synaptic inhibition by GABA or glycine, and is supported by the abnormalities observed in the developing spinal cord and brainstem of KCC2 knock-out mice (Hübner et al., 2001) .
Protein tyrosine kinase (PTK) phosphorylation is considered a key biochemical event in numerous cellular processes, including proliferation, growth, and differentiation, and has also been implicated in synaptogenesis (Catarsi and Drapeau, 1993) . Protein tyrosine kinases are subdivided into the cytosolic nonreceptor family and the transmembrane growth factor receptor family, which includes receptors for insulin and insulin-like growth factor (IGF-1). The maturation of postsynaptic inhibition may require both a cytoplasmic PTK, which increases GABA A receptormediated currents (Moss et al., 1995) , and insulin, which was shown to induce a rapid translocation of GABA A receptors from intracellular compartments to the plasma membrane (Wan et al., 1997b) . KCC2 is also known to have a C-terminal PTK consensus site (Payne, 1997) . Therefore, the maturation of postsynaptic inhibition may, in addition to other mechanisms, also involve the effects of PTK and insulin acting on KCC2.
Previously, we presented an assay that allows one to determine the direction of KCC2 transport as a function of extracellular K ϩ concentration (Jarolimek et al., 1999) . A major advantage of the assay is that the driving force for the transporter is set by defined intracellular and extracellular ion concentrations and that GABA A currents are not confounded by the influence of HCO 3 Ϫ ions (Kaila et al., 1993) . In this study, we used the assay and show that PTK inhibitors reduce KCC2-mediated transport. Furthermore, we provide evidence that insulin and IGF-1 in conjunction with a cytosolic PTK, c-Src, rapidly activate KCC2.
MATERIALS AND METHODS
Cell culture. Pregnant Wistar rats were anesthetized with ether and killed by decapitation. The embryos were removed, placed in sterile, ice-cold Gey's buffered salt solution [containing (in mM): 137 NaC l, 5 KC l, 0.3 MgSO 4 , 1 NaH 2 PO 4 , 1.5 CaCl 2 , 2.7 NaHC O 3 , 0.2 K H 2 PO 4 , 1 MgC l 2 , and 5 glucose, at pH 7.4], and immediately decapitated. Hippocampal anlage from 14-d-old embryos was mechanically dissociated and plated on a primary culture of glial cells from the same area. C ell culture conditions were the same as described previously (Jarolimek and Misgeld, 1992) . For the incubation experiments, neurons were raised in medium containing either bovine insulin (30 g /ml; Life Technologies, Paisley, UK) or IGF-1 (50 ng /ml; Sigma, Deisenhofen, Germany) from 2-5 or 2-8 d in culture (DIC), during which the medium was replaced two to three times. Afterward, half of the medium was exchanged twice per week with medium lacking insulin or IGF-1. Sister control cultures, raised in the absence of insulin, were obtained from the same embryos and recorded on the same days. Cultures raised with insulin contained considerably larger cell numbers than their counterparts (data not shown).
Electrophysiolog ical recordings. Recordings were performed at room temperature (22-25°C) in the whole-cell voltage-clamp configuration with a patch-clamp amplifier Axopatch 200 B (Axon Instruments, Foster C ity, CA). The composition of the extracellular solution was (in mM): 156 NaC l, 1 C sC l, 2 KC l, 2 C aC l 2 , 1 MgC l 2 , 15 glucose, and 10 H EPES, pH 7.3. Composition of the patch pipette solution was (in mM): 3.5 NaC l, 5 KC l, 130 K-glucuronate, 0.25 C aC l 2 , 0.5 MgC l 2 , 10 glucose, 10 HEPES, 5 5-N-(2,6-dimethylphenylcarbamoylmethyl)-triethylammonium bromide (QX314), and 0.1 or 2 Mg-ATP, pH 7.3. For a more detailed description of the assay, see Jarolimek et al. (1999) . E xtracellular solutions were applied by a multibarreled perf usion system that was positioned ϳ250 m apart from the soma of the recorded cell. All experiments were performed with 10 M 6,7-dinitroquinoxaline-2,3-dione and 1 M DL-2-amino-4-methyl-5-phosphono-3-pentenoic acid in the extracellular solution to block glutamatergic synaptic currents. The remaining currents could be completely blocked by application of 20 M bicuculline (Jarolimek et al., 1999) . Drugs were from Sigma, except lavendustin A (C albiochem, Schwalbach, Germany). Insulin or IGF-1 were added to the extracellular solution. c-Src (recombinant pp60 c-Src ; Upstate Biotechnology, from Biomol, Hamburg, Germany) was added to the patch pipette solution directly before the experiment. For control experiments, c-Src was heat-inactivated at 60°C for 15 min. For all experiments with acute application of insulin, IGF-1, and /or c-Src, patch pipette solution containing 2 mM Mg-ATP was used.
Patch pipettes were fabricated from borosilicate glass (Hilgenberg, Malsfeld, Germany), and their resistances to bath ranged from 2.5 to 4.5 M⍀. The access resistance was estimated from the amplitude of the capacitive current evoked by a 5 mV square pulse. Only access resistances between 10 and 20 M⍀ were accepted and routinely checked during the recording. For a determination of the liquid junction potential between the patch pipette and the extracellular solution, see Jarolimek et al. (1999) . All values were corrected by Ϫ14 mV. Recordings were started Ͼ5 min after the whole-cell configuration was established to allow adequate time for QX314 to take effect and for anions to equilibrate. After 5 min, no additional change in dendritic or somatic E GABA was observed for the duration of recording (up to 2 hr). GABA (1 mM; Sigma) was applied by pressure ejection (1-20 kPa; 20 -40 msec) every 15 sec from a pipette with a Ͻ1 m opening. I GABA was measured in the presence of TTX (0.3 M; Alomone Labs, Jerusalem, Israel) to avoid superposition of I GABA and action potential-dependent spontaneous I P-SC s (sI PSC s). Currents were recorded at holding potentials (V H ) near E GABA . After 15-45 sec at a new V H , the current amplitudes induced by three consecutive applications were averaged. Despite the rapid exchange of the extracellular solution (ϳ0.5 sec) around the neuron, effects of drugs were determined Ͼ1 min after start of the application. During this time, V H was set to E GABA . For the analysis of sI PSC s, we first determined the reversal potential, and, from the reversal potential, V H was changed in small steps to determine the voltage dependence of synaptic currents.
Data anal ysis. Data were filtered at 1.3 kHz with a four-pole Bessel filter and were acquired and analyzed with pC lamp6 (Axon Instruments) and Igor Pro (WaveMetrics Inc., Eugene, OR). The amplitudes of sI P-SC s were analyzed with a program written in our laboratory (Jarolimek and Misgeld, 1997) . The reversal potential of I GABA was determined by fitting the current-voltage plot by a linear regression (r Ն 0.95). Somatic sI PSC s and all sI PSC s recorded in the presence of a blocker for cationanion transporters were fitted together only if r Ն 0.75. The 10 largest inwardly and outwardly directed sI PSC s, respectively, were averaged for each data point of the current-voltage relationship. Statistic analysis of data are reported as mean Ϯ SEM.
Reverse transcription-PCR . To evaluate levels of KCC2 mRNA in neurons, a semiquantitative reverse transcription (RT)-PCR approach was undertaken in which fragments corresponding to the KCC2 and the internal standard, neurofilament light chain (N FL) (Moshnyakov et al., 1996) , transcripts were coamplified. The specificity of the reaction conditions was determined by amplif ying the cDNA with either the KCC2 or N FL primer pair (see below) individually and then sequencing the reaction products. Fragments corresponding to the KCC2 and N FL transcripts so amplified were purified and 32 P-dC TP labeled to generate specific probes for the Southern blot analysis (see below). Conditions for the cDNA synthesis and PCR (given below) were chosen such that the reaction products were hardly visible after 20 amplification cycles but were abundant after 30 cycles (see Fig. 6C1 ). Because the reaction products were well within the exponential phase of the PCR, all quantitations were done on reaction products amplified for only 20 cycles. Reaction products were electrophoresed on a 2% agarose gel, subjected to Southern blot analysis, and quantified with a bio-imaging analyzer (F UJI X BAS1000; Fujifilm, Tokyo, Japan). To maximize accuracy, the same blots were stripped and then probed individually with either KCC2-or N FL -labeled fragments (see Fig. 6C2 ). After correcting for the amount of N FL amplified, the relative levels of KCC2 expressed by neurons after treatment with insulin to sister controls was determined for three independent experiments and expressed as a ratio (see Fig. 6 D) . For each cDNA, the amplifications, Southern blots, and quantitations were repeated four times.
cDNA reactions were conducted on RNA prepared from sister control and insulin-treated cultures, using Moloney murine leukemia virus reverse transcriptase and random hexanucleotide primers, and had a final volume of 30 l. For PCR reactions, 0.5 l of the cDNA reaction was used along with 0.5 M of each of the four primers (given below), 0.25 mM of each dN TP, 10 l of 10ϫ buffer, 0.5 l of Taq polymerase, and 1 mM MgC l 2 . The following primers were used: 5Ј-GCAGCCCC TTCA-TCAACAGCAC -3Ј and 5Ј-CATCGC TGGGAAGAGGTAAGC -3Ј, which amplified a 559 bp fragment of the KCC2 transcript, and 5Ј-TGCACGAGGAAGAGATCGCCGAGC T-3Ј and 5Ј-C TGTAAGC T-GCAATC TCAATGT-3Ј, which amplified a 495 bp fragment of the N FL transcript.
Immunoc ytochemistr y. The abundance of KCC2 protein in neurons treated with insulin and in untreated controls was visualized with an antibody whose specificity and utility has been described previously (Williams et al., 1999) . Neurons cultured on coverslips were fixed for 10 min at room temperature with 4% paraformaldehyde prepared in PBS. After brief washes with PBS, they were permeabilized by incubation for 5 min at room temperature in a 0.2% Triton X-100 (Tr)-PBS solution, rinsed again with PBS, and then incubated in a solution containing 0.2% Tr and 4% goat serum (GS)-PBS for 30 min at room temperature. The coverslips were incubated in the primary antibody (1:200 dilution; 0.1% Tr and 2% GS -PBS) overnight at 4°C. After rinses in 1% GS -PBS, the FI TC -conjugated anti-rabbit secondary antibody was added (1:200 dilution; Jackson ImmunoResearch, West Grove, PA), and the coverslips were incubated for 2 hr at room temperature. The coverslips were then rinsed, mounted on slides, visualized, and photographed with an Axio Plan 2 microscope (Z eiss, Oberkochen, Germany).
RESULTS

KCC2 activity distinguishes between two types of neurons
Whole-cell recordings from embryonic (E14) hippocampal neurons 27-31 DIC were performed under conditions of 15 mM (10 mM Cl Ϫ and 5 mM Br Ϫ ) (cf. Jarolimek et al., 1999 ) permeant anions in the patch pipette and 2 mM K ϩ in the extracellular
Only cells with membrane potentials more negative than Ϫ55 mV were included in the analysis. We applied GABA (1 mM) focally to either the soma or a dendrite of a single cell. The distance between the somatic and dendritic applications was at least 100 m. Responses to GABA applications allowed us to discriminate two types of cells, which we termed type 1 and type 2. In type 1 neurons, the reversal potential (E GABA ) for dendritic currents was more negative than E GABA for currents induced by somatic applications (Ϫ81.3 Ϯ 2.9 and Ϫ59.5 Ϯ 1.6 mV, respectively; p Յ 0.001; n ϭ 4). Furosemide (100 M) changed the driving force of the currents induced by focal dendritic applications (Fig. 1 A1) . Plots of current amplitudes versus holding potential (V H ) revealed a positive shift of dendritic E GABA in the presence of furosemide (Fig. 1 A2) . In the same cells, currents induced by focal somatic applications were not altered (Fig. 1 A1) . In type 2 neurons (Fig. 1 B) , on the other hand, there was no difference between E GABA obtained with either dendritic or somatic applications (Ϫ57 Ϯ 0 and Ϫ56 Ϯ 1.3 mV, respectively; n ϭ 4), and furosemide had no effect on E GABA for dendritic currents.
Pharmacological blockade of ionotropic glutamate receptors allowed us to measure sIPSCs mediated by GABA A receptors. Cells exhibiting little spontaneous synaptic activity were not considered in this study. In half of the hippocampal neurons (type 1), the simultaneous occurrence of inward and outward sIPSCs (Fig. 2 A1) prevented the determination of a single reversal potential (E rev ). The other half (type 2) was characterized by sIPSCs that were either outward or inward depending on the respective V H (Fig. 2 B1) . Only in type 1 neurons was it possible to alter the driving force for sIPSCs with the cation-anion transport blocker furosemide.
Figure 2 A1 shows a type 1 hippocampal neuron. Application of furosemide (100 M) reversed the direction of synaptic currents in Ͻ1 min. This effect was reversible during washout of furosemide. When amplitudes of the sIPSCs of this neuron were measured at varying V H (Ϫ69 to Ϫ85 mV), the data points could be fitted by two linear regression lines (Fig. 2 A2) , and two different reversal potentials could be extrapolated. According to results obtained with focal GABA applications, data points yielding the more negative reversal potential are from dendritic sIPSCs. The other line connected values for somatic sIPSCs. Data points obtained in the presence of the transport blocker furosemide could be fitted with the somatic currents (Fig. 2 A2) . In contrast, for a type 2 neuron (Fig. 2 B) , measurement of sIPSC amplitudes at varying V H allowed determination of a single reversal potential. In this cell, furosemide had no effect.
According to the data reported above, in type 1 neurons, dendritic sIPSCs can be discriminated from somatic sIPSCs by their respective driving forces. Driving forces for dendritic sIPSCs approached those of somatic sIPSCs during blockade of Cl Ϫ transport by furosemide. Bumetanide mimicked the effects of furosemide (Fig. 3A) but was somewhat less effective than furosemide. At high concentration (100 M), bumetanide as well as furosemide reversed the direction of sIPSCs (n ϭ 3) (Fig. 3A) . At low concentration, bumetanide (25 M) had no effect on spontaneous synaptic currents, whereas application of 25 M furosemide to the same type 1 neuron increased the amplitude of inward sIPSCs and decreased those of outward sIPSCs (n ϭ 4). The stilbene derivative 4,4Ј-diisothiocyanatostilbene-2,2Ј-disulfonic acid (DIDS) was more effective than furosemide, but recovery was not always complete ( Fig. 3 B, C) . These pharmacological characteristics match those of KCC2 expressed in human embryonic kidney cells (Payne, 1997) .
The data indicated that a Cl Ϫ gradient exists between soma and dendrites of type 1 neurons, because Cl Ϫ transport exceeds the Cl Ϫ load provided by the patch pipette solution in the A, Focal application of GABA (1 mM) to a type 1 neuron. A1, Furosemide (100 M) reversed the direction of GABA currents at the dendrite but not at the soma of the same cell. Below the traces, the driving force (V H -E GABA ) is indicated. Somatic E GABA was Ϫ64 mV, and dendritic E GABA was Ϫ78 mV. con, Control; furo, furosemide; wash, washout. A2, Plots of GABA current amplitudes versus V H revealed a positive shift of dendritic E GABA in furosemide (100 M; f) compared with control (Ⅺ) and washout (ƒ). B, Focal application of GABA (1 mM) to a type 2 neuron. There was no difference between E GABA in the dendrite (Ⅺ) and in the soma (E) of the same cell. Furosemide (100 M; f) did not alter E GABA of dendritic currents. Control, Ⅺ; washout, ƒ. , and furosemide (100 M; ) had no effect. Con, Control; furo, furosemide.
dendrites of the neurons (Jarolimek et al., 1999) . In contrast, type 2 neurons possess a uniform distribution of intracellular [Cl Ϫ ], because they lack net outward Cl Ϫ transport activity. These findings are summarized in Figure 4 . In type 1 neurons (Fig.  4 A1) , E GABA for dendritic GABA currents shifted to positive values in furosemide (⌬V rev ) (Fig. 4 A2) . For the quantification of furosemide effects on sIPSCs, we measured V H at which the first outward sIPSCs with amplitudes twice the noise appeared. Furosemide induced a significant positive shift in this value (Fig.  4 A3) . In type 2 neurons, in which dendritic and somatic E GABA were the same (Fig. 4 B1) , furosemide had no effect on dendritic E GABA (Fig. 4 B2) . V H at which the first outward sIPSCs appeared was also not changed (Fig. 4 B3) . In conclusion, a furosemide-sensitive KCC generates the somatodendritic [Cl Ϫ ] gradient in type 1 neurons, whereas in type 2 neurons KCC activity is absent.
Outward transport of chloride requires tyrosine kinase activity
Neuron-specific KCC2 differs from the widely expressed KCC1 in a PTK consensus site (Payne, 1997 ). Hence, we tested the effect of PTK inhibitors on Cl Ϫ outward transport in type 1 neurons. Perfusion of lavendustin A (10 M), a membrane-permeable inhibitor of PTK (O'Dell et al., 1991) , like furosemide, resulted in an increase of inward and a decrease of outward sIPSCs that was fully reversible only after a single application (Fig. 5A ). This treatment also resulted in a decrease in the frequency of sIPSCs. To quantify the effect of lavendustin A (11 applications to five cells), we determined the amplitude ratio of outward to inward sIPSCs, which was strongly reduced during the application (0.51 Ϯ 0.07; p Յ 0.001) (Fig. 5B) . Control experiments were performed using type 2 neurons because these cells have no KCC2-mediated transporter activity. Lavendustin A was applied at different V H , and the resultant sIPSCs were measured (17 applications to seven type 2 neurons). Under these conditions, the frequency and amplitudes of inward (0.58 Ϯ 0.12) and outward sIPSCs (0.6 Ϯ 0.08) normalized to control were reduced (Fig.  5C ), but their ratio did not change.
Another membrane-permeable inhibitor of PTK, genistein (50 M) (Akiyama et al., 1987) , produced a reversible decrease (13 applications to nine cells) in the amplitude ratio of outward to inward sIPSCs (0.25 Ϯ 0.06; p Յ 0.001) in type 1 neurons (Fig.  5B) . In contrast, daidzein (50 M), the inactive analog of genistein (Akiyama et al., 1987) , when applied to neurons that responded to genistein (six applications to four cells), had no effect on the ratio of outward to inward currents (1.2 Ϯ 0.14) (Fig.  5B) . In type 2 neurons (18 applications to three cells), genistein did not reduce the mean amplitude of either outward (0.99 Ϯ 0.08) or inward (0.84 Ϯ 0.13) sIPSCs (Fig. 5C) .
To circumvent effects of PTK inhibitors on spontaneous activ- A2, E GABA was determined for currents induced by focal application of GABA (1 M) to the dendrite of type 1 neurons; furosemide (100 M) reversibly shifted E GABA to more positive potentials ( p Յ 0.001). A3, Furosemide (100 M) induced shifts in the V H to more positive potentials ( p Յ 0.01) at which the first sIPSCs with amplitudes twice the noise appeared. B1 displays a type 2 neuron with an even [Cl Ϫ ] in the dendrites and in the soma. B2 displays focal applications of GABA (1 mM) to dendrites of type 2 neurons. No shift in E GABA occurred when furosemide (100 M) was applied. B3, Same as A3 for type 2 neurons, but there was no effect of furosemide (100 M). con, Control; furo, furosemide; wash, washout.
ity, we applied GABA focally to dendrites of type 1 neurons and measured ⌬V rev for GABA currents. Genistein shifted E GABA to positive values (⌬V rev was ϩ7.5 Ϯ 1.1 mV; n ϭ 10) and caused a new steady state, which was reached within 3 min after application and was reversible in most instances. Genistein, however, had no effect on E GABA if GABA was applied to the soma of cells (n ϭ 3) because somatic [Cl Ϫ ] intra is determined by the Cl Ϫ load through the patch pipette. We next compared ⌬V rev induced by genistein or furosemide if they were applied to the same type 1 or type 2 cell (n ϭ 12). As shown in Figure 5 , D1 and D2, a given cell responded with almost the same ⌬V rev to either genistein or furosemide. The correlation of ⌬V rev induced by genistein or furosemide was highly significant (r ϭ 0.98), strongly suggesting that both drugs acted by blocking the same pathway (Fig. 5E) . Furthermore, the slope of the curve revealed that the genistein effect amounted to 80% of the furosemide effect.
Neuronal chloride channels, ClC-3 and ClC-2, are known to be activated or blocked by activators of protein kinase A and protein kinase C, respectively (Smith et al., 1995) . Therefore, we applied forskolin, an activator of adenylylcyclase, (20 M; n ϭ 5), and phorbol-12-mystirate-13-acetate, an activator of protein kinase C (1 M; n ϭ 3), to the bath solution. None of them had an effect on the Cl Ϫ gradient and furosemide sensitivity (data not shown), although spontaneous synaptic activity increased as described previously (Capogna et al., 1995) .
Developmental activation of outward chloride transport
We determined the developmental onset of type 1 neurons in cultures derived from hippocampus. There were time points when either type 1 or type 2 neurons predominated and a transitory period wherein both types existed. Type 1 neurons were the predominant cell type only after 35-44 DIC (26 of 29 cells), whereas type 2 predominated up to 23 DIC (18 of 19 cells). The time of appearance of type 1 neurons could be shortened by incubation with a growth factor that activates PTK. In hippocampal cultures raised in insulin (30 g/ml), type 1 neurons predominated as early as 21-24 DIC (17 of 18 cells). In contrast, very few type 1 neurons (1 of 12 cells) were found in sister cultures raised without insulin (Fig. 6 A) . The same results were obtained with physiological concentrations of IGF-1 (50 ng/ml).
To determine whether the difference in Cl Ϫ transport between the two groups of neurons was attributable to differential expression of KCC2, we amplified KCC2 transcript by single-cell RT-PCR from individual type 1 and type 2 neurons. Single-cell RT-PCR revealed no difference because 15 of 18 type 1 neurons and 10 of 15 type 2 neurons contained KCC2 mRNA (data not shown). To quantify the relative expression of KCC2 transcript in type 1 and type 2 neurons, we determined the abundance of KCC2 mRNA in 21-24 DIC cultures treated with insulin and in 30 sec) , the inactive analog of genistein. C, In type 2 neurons, inward currents and outward currents normalized to control at the respective V H were reduced, but the ratio did not change. D1, Currents induced by focal applications of GABA (1 mM) to a dendrite decreased or reversed in direction, respectively, when genistein (50 M) or furosemide (100 M) were applied to a type 1 neuron (V H of Ϫ75 mV). At E GABA (V H of Ϫ85 mV), there was an increase in inward currents in genistein and furosemide. D2, The current-voltage relationship for the neuron shown in D1 revealed a positive shift in E GABA (⌬V rev ) in genistein (f) and furosemide (F). Control, Ⅺ; washout, ƒ. E, Correlation of ⌬V rev induced by genistein (50 M) and furosemide (100 M) in 12 neurons was highly significant (r ϭ 0.98). con, Control; daidz, daidzein; furo, furosemide; genist, genistein; lav A, lavendustin A; wash, washout. sister control cultures. Semiquantitative RT-PCR, wherein KCC2 mRNA was amplified and normalized to the expression of NFL, indicated that both cultures expressed comparable amounts of KCC2 (Fig. 6 D) . In addition, immunocytochemical visualization of KCC2 protein revealed that it was abundant in both types of cultures (Fig. 6 B) . Thus, we concluded that the onset of transporter activity cannot be correlated with the amount of mRNA or with the mere presence of KCC2 protein.
The data presented above suggested that neurons with passive E C l Ϫ as well as neurons with functional transport contained KCC2 protein. Furthermore, PTK appeared to play a major role in regulating the transport. To test whether PTK could activate the transport, we applied insulin (30 g/ml) in the bath for at least 30 min. This had no effect on its own (n ϭ 3). However, if the application of insulin (30 g/ml; n ϭ 7) or IGF-1 (50 -100 ng/ml; n ϭ 3) was combined with the perfusion (15 min before application of insulin or IGF-1) of a cytoplasmic PTK (c-Src, 60 U/ml) via the recording pipette, type 2 cells could acquire type 1 activity within 5 min (Fig. 7) . The change manifested itself in the appearance of inward and outward sIPSCs at a holding potential, at which the cell had shown previously inward currents only (Fig.  7B) . The application of c-Src alone (30 or 60 U/ml for 30 min) was not effective (n ϭ 6). Furthermore, whereas the cells recorded with c-Src did not respond to furosemide, furosemide induced a shift in the driving force for sIPSCs in the same cells after insulin or IGF-1 application (n ϭ 9) (Fig. 7B) . To confirm that active tyrosine kinase was required for the change from type 2 to type 1 characteristics, we used heat-inactivated c-Src, which was unable to support the insulin effect (n ϭ 3).
DISCUSSION
KCC2-mediated outward transport of chloride
In a previous study (Jarolimek et al., 1999) , we demonstrated that a furosemide-sensitive K ϩ /Cl Ϫ cotransporter generates a pronounced somatodendritic [Cl Ϫ ] gradient in cultured midbrain neurons provided that appropriate intracellular and extracellular K ϩ and Cl Ϫ concentrations are chosen. The somatodendritic gradient is built up by [Cl Ϫ ] in the patch pipette solution, which serves as a Cl Ϫ source, and the K ϩ /Cl Ϫ cotransporter, which counteracts that Cl Ϫ load. This gradient makes it possible to study Cl Ϫ regulation through K ϩ /Cl Ϫ cotransport in neurons by measuring differences between somatic and dendritic E GABA . Using this assay, we could identify two groups of neurons in hippocampal cultures on the basis of the respective GABA A receptor-mediated synaptic currents generated by the input of spontaneously discharging inhibitory neurons. One group (type 1) comprised mature neurons in which dendritic and somatic sIPSCs could be discriminated by their different driving forces. Immature neurons constituted the second group (type 2) and revealed no difference between dendritic and somatic sIPSCs. Furosemide sensitivity of E GABA and a difference in somatic and dendritic E GABA were found only in type 1 neurons. Based on the rank order of potencies of the blockers for KCC2 (Payne, 1997) , we conclude that the somatodendritic Cl Ϫ gradient is established by KCC2. Keeping with this notion, our previous study (Jarolimek et al., 1999) showed that the direction of transport is sensitive to small changes of [K ϩ ] extra , as predicted by the thermodynamic properties of an electroneutral K ϩ /Cl Ϫ cotransport. As expected, there was no interference with voltage-gated Cl Ϫ channels because their influence on the described Cl Ϫ homeostasis was very small and could be identified only after a complete blockade of Cl Ϫ transport (Smith et al., 1995) .
KCC2 function requires tyrosine kinase activity
KCC2 is a member of the family of cation-anion cotransporters that regulate cell volume and are essential for salt and water transport across epithelia. To become activated, they are either phosphorylated or dephosphorylated. Abnormalities of erythrocyte K ϩ /Cl Ϫ cotransport in fgr Ϫ/Ϫ /hck Ϫ/Ϫ double-mutant mouse demonstrate that Src family kinases are involved in the regulation of membrane transport. In this case, the kinases are likely to negatively regulate a cotransporter-activating phosphatase (De Franceschi et al., 1997) . Another member of this family, NKCC1, is regulated by protein kinases A and C, as has been shown for secretory epithelia (for a review of the literature, see Russel, 2000) . Neuron-specific KCC2, in contrast to the ubiquitously expressed KCC1, has a tyrosine kinase consensus site (Payne, 1997) . Recently, the inhibitory effect of phosphatase inhibitors demonstrated that serine-threonin phosphorylation events regulate KCC2 activity in oocytes (Strange et al., 2000) . Thus, there are many reasons to believe that phosphorylation could be important in regulating KCC2 activity.
Genistein and lavendustin A, both membrane-permeable PTK inhibitors, had a furosemide-like effect on the somatodendritic Cl Ϫ gradient in mature neurons. The comparable strength of furosemide and genistein indicated that most of the developmental increase in the number of cultured neurons with KCC2 activity was attributable to phosphorylation. In a recent study conducted in Xenopus laevis oocytes, site-directed mutagenesis of exogenously expressed KCC2 (Strange et al., 2000) suggested that the predicted C-terminal tyrosine kinase consensus site of KCC2 (Payne, 1997) may not be phosphorylated. However, we believe that factors required in neurons for activation of KCC2 are not present in that artificial expression system because concentrations of genistein twice as high as those used in our study had no effect in the oocytes. A synergistic regulation of the efficacy of inhibitory synapses is suggested by the fact that tyrosine phosphorylation also increases amplitudes of GABA A currents (Moss et al., 1995; Wan et al., 1997a) . Thus, the phosphorylation step leading to activation of KCC2 may be part of the overall maturation of GABAergic synapses.
Development of KCC2-mediated outward transport of chloride
We noted an increasing number of cells with transport activity when recording from mature cultures. Maturation of neurons, as determined by the relative amount of type 1 neurons, could be accelerated if cultures were transiently incubated in insulin or in physiological concentrations of IGF-1, suggesting that the effect was mediated by the IGF-1 receptor. Insulin is known to be synthesized by hippocampal neurons (Bartlett et al., 1991) and can be released in a calcium-dependent manner during depolarization (Clarke et al., 1986; Wei et al., 1990) . GABAergic stimulation of immature neurons in hippocampal culture leads to a Ca 2ϩ influx, but it reduces the levels of intracellular Ca 2ϩ in mature neurons (Berninger et al., 1995) .
Responses to GABA with an elevation of [Ca 2ϩ ] i have been correlated with KCC2 expression in developing hippocampal cultures. A nonlinear relationship between the mRNA of KCC2 and its functional effects was observed. Ca 2ϩ influx during GABA application persisted at a time at which expression of mRNA for KCC2 increased. The transformation of GABA responses could be attributed to a reduced rate of Cl Ϫ uptake as a result of decreasing NKCC1 activity, as well as to increasing KCC2 activity (Ganguly et al., 2001 ). Other factors to consider when monitoring Ca 2ϩ influx are developmental changes in the kinetics of Ca 2ϩ current activation attributable to a reduced expression of L-type channels (Pravettoni et al., 2000) and increases in resting membrane potentials. Because KCC2 protein was abundant and because comparable amounts of mRNA for KCC2 were present both in insulin-treated and untreated cultures, we concluded that the presence of KCC2 protein alone is not sufficient to induce transport activity. Assuming that tyrosine kinase phosphorylation provides the key to activate KCC2, we applied insulin or IGF-1 in conjunction with intracellular perfusion of c-Src protein and found that the transport was rapidly activated. Perfusion with c-Src alone was not sufficient for activation of the transport, excluding the possibility that c-Src mediated the entire response to IGF-1. Our data, however, do not provide direct evidence for upregulation of tyrosine kinase during chronic insulin exposure. Also, an upregulation of other Figure 7 . Instantaneous transformation of a type 2 into a type 1 neuron. A, Only inward sIPSCs occurred at the indicated V H during recording with c-Src (60 U/ml) in the patch pipette solution. After 10 min of insulin application (30 g/ml), simultaneous outward and inward currents were recorded at the same V H . B, In this neuron, sIPSCs were fitted by a single linear current-voltage relationship. During insulin application, sIPSCs appeared that had to be fitted by a separate line. The change reversed during application of furosemide (100 M), which had been ineffective before insulin application (data not shown). con, Control; furo, furosemide; wash, washout.
KCCs, which may contribute to net Cl Ϫ outward transport, was not excluded.
IGF-1 is known to rapidly activate calcium channels by phosphorylation of a subunit via a cytosolic PTK (Bence-Hanulec et al., 2000) . An alternative mechanism can be inferred from studies demonstrating that insulin-induced potentiation of NMDA receptor activity does not result from direct phosphorylation of the receptor but from phosphorylation of associated C-terminal tails of anchoring or signaling proteins (Skeberdis et al., 2001) . Insulin is also known to potentiate GABA A receptor currents by recruitment of functional GABA A receptors to postsynaptic CA1 synapses (Wan et al., 1997b) . However, because high concentrations of insulin were necessary to potentiate the GABA A receptor in that study, it is likely that the effect was mediated via interaction with the IGF-1 receptor that is expressed at high levels in the developing and adult hippocampus (Kar et al., 1993) . Interestingly v-Src kinase has been shown to phosphorylate and activate IGF-1 receptors (Peterson et al., 1996) . Therefore, endogenous c-Src, once activated, might act via both direct and indirect mechanisms, creating a positive feedback cycle to drive the phosphorylation mechanism mediating KCC2 activity to higher levels.
In conclusion, the rapid activation of KCC2-mediated transport by IGF-1-insulin and c-Src in cultured neurons indicates that development of neuronal K ϩ /Cl Ϫ cotransport requires cooperation of a growth factor with PTK-dependent phosphorylation. In this regard, KCC2 is similar to ionotropic receptors and other ion channels whose function is also regulated by PTK-dependent phosphorylation. Transcriptional mechanisms, although known to regulate KCC2 levels in the brain, are not sufficient for the induction of KCC2 activity, at least in cultured neurons. Our studies show that tyrosine phosphorylation is important for rapidly regulating a transport in neurons, which determines the efficacy of postsynaptic inhibition. What may the role of phosphorylation of KCC2 throughout postnatal life be? The very fast and almost complete effect of PTK inhibitors suggested a high turnover rate of phosphorylation and dephosphorylation. In concert with the regulation of GABA A receptors by Src family kinases, fast regulation of KCC2 activity and, hence, postsynaptic inhibition may be important for synaptic plasticity and network excitability. Furthermore, protein tyrosine phosphorylation has been implicated in modifications of neuronal function in pathological conditions such as epilepsy (Sanna et al., 2000) . A reduction of KCC2-mediated transport by furosemide promotes epileptiform activity in neuronal networks (Jarolimek et al., 1996) , whereas activation of the transport might counteract an excessive enhancement of NMDA receptor-dependent excitatory transmission induced by c-Src (Yu and Salter, 1999) . Given the prominent role of synaptic inhibition in mediating many brain functions and dysfunctions, modulation of KCC2 activity by PTKs may be important in a wide range of physiological and pathological processes in the CNS.
